Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,497 | -13,237 | -10,198 | -7,513 | -3,845 |
| Depreciation Amortization | 1 | 7 | 6 | 6 | 6 |
| Accounts payable and accrued liabilities | 174 | -852 | -888 | -607 | -224 |
| Other Working Capital | -759 | -1,311 | -1,454 | -1,309 | -1,358 |
| Other Operating Activity | 78 | 2,792 | 2,503 | 1,748 | 773 |
| Operating Cash Flow | $-3,002 | $-12,602 | $-10,032 | $-7,675 | $-4,649 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -5 | -5 | -3 | -3 |
| Investing Cash Flow | $0 | $-5 | $-5 | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,303 | 6,597 | 3,879 | 3,231 | 1,970 |
| Financing Cash Flow | $1,303 | $6,597 | $3,879 | $3,231 | $1,970 |
| Beginning Cash Position | 4,008 | 10,018 | 10,018 | 10,018 | 10,018 |
| End Cash Position | 2,308 | 4,008 | 3,860 | 5,571 | 7,336 |
| Net Cash Flow | $-1,700 | $-6,010 | $-6,158 | $-4,447 | $-2,682 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,002 | -12,602 | -10,032 | -7,675 | -4,649 |
| Capital Expenditure | 0 | -5 | -5 | -3 | -3 |
| Free Cash Flow | -3,002 | -12,607 | -10,037 | -7,678 | -4,652 |